The first human trial of a vaccine to prevent the coronavirus could advance to the next step this spring, Moderna Chairman Noubar Afeyan said Thursday. “It’s difficult to put a specific date on things just because it’s a very dynamic situation,” Afeyan told CNBC’s Meg Tirrell. “We’ve entered phase 1 trials. ... We’ll enter hopefully phase 2 trials, we expect that to happen in the spring, perhaps early summer. CNBC
Friday, April 3, 2020
Phase 2 of coronavirus vaccine human trials may begin in spring, Moderna chairman says
The first human trial of a vaccine to prevent the coronavirus could advance to the next step this spring, Moderna Chairman Noubar Afeyan said Thursday. “It’s difficult to put a specific date on things just because it’s a very dynamic situation,” Afeyan told CNBC’s Meg Tirrell. “We’ve entered phase 1 trials. ... We’ll enter hopefully phase 2 trials, we expect that to happen in the spring, perhaps early summer. CNBC
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment